Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding Professional audiences…
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A Professional…
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing…
Lucid Diligence Brief: NEOK Bio $75M Series A
Lucid Diligence Brief: NEOK Bio $75M Series A Professional audiences only. Not…
Lucid Diligence Brief: AAVantgarde Bio $141M Series B
Lucid Diligence Brief: AAVantgarde Bio $141M Series B Professional audiences…
Lucid Diligence Brief: Thermo Fisher to acquire Clario
Lucid Diligence Brief: Thermo Fisher to acquire Clario Professional audiences…
Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027
Lucid Diligence Brief: Evaxion $7.2m runway extension to H2 2027 Professional…
Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka
Lucid Diligence Brief: 4DMT APAC License of 4D-150 Gene Therapy to Otsuka…
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health
Lucid Diligence Brief: Human Health A$8.5m raise in women’s health Professional…
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera
Lucid Diligence Brief: Novo Nordisk proposal to acquire Metsera Professional…
Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership
Lucid Diligence Brief: Lilly and NVIDIA AI Supercomputer partnership…
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD
Lucid Diligence Brief: GSK licenses Empirico's siRNA in COPD Professional…